Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group

Authors: Hyndiuk R.A.; Eiferman R.A.; Caldwell D.R.; Rosenwasser G.O.; Santos C.I.; Katz H.R.; Badrinath S.S.; Reddy M.K.; Adenis J.P.; Klauss V.

Source: Ophthalmology, Volume 103, Number 11, 1 November 1996 , pp. 1854-1862(9)

Publisher: Elsevier

Keywords: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Fluoroquinolone/adverse effects/*therapeutic use; Antibiotics, Aminoglycoside/adverse effects/*therapeutic use; Bacteria/isolation & purification; Cefazolin/adverse effects/*therapeutic use; Cephalosporins/adverse effects/*therapeutic use; Child; Ciprofloxacin/adverse effects/*therapeutic use; Comparative Study; Cornea/microbiology; Corneal Ulcer/*drug therapy/microbiology; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial/*drug therapy/etiology; Female; Human; Male; Middle Age; Ophthalmic Solutions; Prospective Studies; Support, Non-U.S. Gov't; Tobramycin/adverse effects/*therapeutic use

Language: English

Document Type: Research article

Publication date: 1996-11-01

• In this: publication
• By this: publisher
• In this Subject: Ophthalmology
• By this author: Hyndiuk R.A. ;  Eiferman R.A. ;  Caldwell D.R. ;  Rosenwasser G.O. ;  Santos C.I. ;  Katz H.R. ;  Badrinath S.S. ;  Reddy M.K. ;  Adenis J.P. ;  Klauss V.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers